Literature DB >> 7633282

Malignant oral tumours in Sweden 1960-1989--an epidemiological study.

J Ostman1, G Anneroth, H Gustafsson, B Tavelin.   

Abstract

Epidemiological data from the Swedish Cancer Registry of new cases of malignant oral tumours in Sweden 1960-1989 are presented, including the total number and the age-standardised incidence rate per 1 million population, by site and sex, (I(s)). An analysis of the various histopathological types of malignant oral tumours in the different sublocations is also given. A comparison is made between the three 10-year periods 1960-1969, 1970-1979 and 1980-1989 regarding total number and I(s). The total number of cases, 17,158, represented 1.8% of all newly diagnosed cancers in Sweden. The following relative frequencies were noted for the respective sites: intra-oral region 0.7%, lip 0.6% and pharynx 0.5%. The results indicated an increase in total number and a statistically significant increase of I(s) for malignant lip tumours in females over the whole period. A corresponding increase in total number during the periods 1960-1969 and 1980-1989 and a decrease in I(s) during the periods 1970-1979 and 1980-1989 in lip tumours for males was observed. For males there was an increase in total number and a statistically significant increase in I(s) for malignant tongue tumours, while the corresponding figures for females remained constant. For malignant floor of the mouth tumours there was an increase in total number and a statistically significant increase in I(s) for both men and women. In the intra-oral region, including the sublocations oral cavity-other sites, tongue and floor of the mouth, the male:female ratio was 1.8:1 and I(s) changed from 22.8 (1960-1969) to 29.6 (1980-1989).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7633282     DOI: 10.1016/0964-1955(94)00018-y

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  7 in total

1.  Novel amelanotic and melanotic cell lines NM78-AM and NM78-MM derived from a human oral malignant melanoma.

Authors:  Taka Nakahara; Yuichi Tamaki; Noriko Tominaga; Yoshiaki Ide; Masanori Nasu; Akihiro Ohyama; Soh Sato; Isamu Ishiwata; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2010-02-01       Impact factor: 4.174

2.  The oral health status of pre-treatment head and neck cancer patients.

Authors:  S B Critchlow; C Morgan; T Leung
Journal:  Br Dent J       Date:  2014-01       Impact factor: 1.626

Review 3.  The challenges of defining oral cancer: analysis of an ontological approach.

Authors:  Jose Luis Tapia; Louis J Goldberg
Journal:  Head Neck Pathol       Date:  2011-09-14

4.  Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.

Authors:  Gefter Thiago Batista Correa; Vanessa Fátima Bernardes; Silvia Ferreira de Sousa; Marina Gonçalves Diniz; José Maria Porcaro Salles; Renan Pedra Souza; Alfredo Maurício Batista De-Paula; Ricardo Santiago Gomez; Carolina Cavalieri Gomes
Journal:  Tumour Biol       Date:  2015-06-18

5.  Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma.

Authors:  Xi Yang; Guo-Xin Ren; Chen-Ping Zhang; Guo-Yu Zhou; Yong-Jie Hu; Wen-Jun Yang; Wei Guo; Jiang Li; Lai-Ping Zhong
Journal:  BMC Cancer       Date:  2010-11-11       Impact factor: 4.430

6.  Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial.

Authors:  Sunali S Khanna; Freny R Karjodkar
Journal:  Head Face Med       Date:  2006-10-16       Impact factor: 2.151

7.  Immunological and biochemical markers in oral carcinogenesis: the public health perspective.

Authors:  Sunali Khanna
Journal:  Int J Environ Res Public Health       Date:  2008-12       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.